Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 13.32
-0.18 (-1.33%)
Jul 14, 2026, 9:13 AM CET
Genfit Market Cap
Genfit has a market cap or net worth of €675.33 million as of July 13, 2026. Its market cap has increased by 307.52% in one year.
Market Cap
675.33M
Enterprise Value
724.92M
Revenue
70.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
€13.32
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 675.33M, an increase of 362.34%. That is a compound annual growth rate of 8.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 675.33M | 157.59% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.77B |
| MedinCell | 973.00M |
| Inventiva | 881.33M |
| DBV Technologies | 843.95M |
| Valneva SE | 413.24M |
| Transgene | 206.78M |
| Valerio Therapeutics Société anonyme | 199.78M |
| Cellectis | 184.55M |